PO-432 New combined nanoparticle therapy inhibits metastatic breast tumour growth with superior efficacy and lower side effect profile to docetaxelHassan Alshaker, Dmitri Pchejetski|ESMO Open|2018Cited by 1
Validation of a New Epigenetic-Based Prognostic Blood Test to Predict Prostate Cancer AggressivenessDmitri Pchejetski, Justin Stebbing, Aroul Ramadass et al.|Annals of Oncology|2013Cited by 0
mTOR inhibition overcomes docetaxel chemoresistance in prostate cancer cell and mouse models through downregulation of sphingosine kinase 1Hassan Alshaker, Dmitri Pchejetski, Q. Wang et al.|European Journal of Cancer|2016Cited by 0
Investigating blood cells’ chromosomal conformation patterns as new diagnostic markers for prostate cancerDmitri Pchejetski, Alexandre Akoulitchev, Hassan Alshaker et al.|European Journal of Cancer|2016Cited by 0
PO-356 White blood cells from prostate cancer patients carry distinct chromosome conformationsDmitri Pchejetski, Hassan Alshaker|ESMO Open|2018Cited by 0